Bot, AdrianChiriva-Internati, MaurizioCornforth, AndrewCzerniecki, Brian JFerrone, SoldanoGeles, KennethGreenberg, Philip DHurt, ElaineKoya, Richard CManjili, Masoud HMatsui, WilliamMorgan, Richard APalena, Claudia MPowell Jr , Daniel JRestifo, Nicholas PSpencer, David MVizcardo, RaulWong, Albert JYang, LiliYu, John2014-07-072014Bot, A., M. Chiriva-Internati, A. Cornforth, B. J. Czerniecki, S. Ferrone, K. Geles, P. D. Greenberg, et al. 2014. “Stem cells and cancer immunotherapy: Arrowhead’s 2nd annual cancer immunotherapy conference.” Journal for Immunotherapy of Cancer 2 (1): 6. doi:10.1186/2051-1426-2-6. http://dx.doi.org/10.1186/2051-1426-2-6.2051-1426http://nrs.harvard.edu/urn-3:HUL.InstRepos:12406942Investigators from academia and industry gathered on April 4 and 5, 2013, in Washington DC at the Arrowhead’s 2nd Annual Cancer Immunotherapy Conference. Two complementary concepts were discussed: cancer “stem cells” as targets and therapeutic platforms based on stem cells.en-USImmunotherapyCancer stem cellsHematopoietic stem cellsAdoptive T cell therapyAntibodiesVaccinesJournal Article2014-07-0710.1186/2051-1426-2-6